<?xml version="1.0" encoding="UTF-8"?>
<GaPExchange xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dbGaPEx2.1.5.xsd">

<MetaVariables>
	<Submitter/>
	<Method/>
</MetaVariables>
<MetaLinks/>

<Projects>
	<Project/>
	<Project/>
	<Project/>
</Projects>

<Studies>

<Study source="dbGaP" accession="phs000265.v3.p1" parentStudy="phs000265.v3.p1" createDate="2011-05-04" modDate="2011-10-07">

<Configuration>
	<Data_Provider><![CDATA[
		<table border="1">
		<tr><th>Title</th><th>Name</th><th>Institute</th></tr>
		<tr><td>Principal Investigator</td><td>James Versalovic, MD, PhD</td><td>Baylor College of Medicine, Texas Children&#39;s Hospital, Houston, TX,  USA</td></tr>
		<tr><td>Co-Investigator Clinical</td><td>Robert J. Shulman, MD</td><td>Baylor College of Medicine, Texas Children&#39;s Hospital, Houston, TX,  USA</td></tr>
		<tr><td>Funding Source</td><td>1UH3DK083990-02</td><td>National Institutes of Health, Bethesda, MD, USA</td></tr>
		<tr><td>Clinical Research Coordinator III</td><td>Erica Weidler Baimbridge</td><td>Baylor College of Medicine, Houston, TX, USA</td></tr>
		<tr><td>Clinical Research Coordinator II</td><td>Michelle Rubio-Gonzales</td><td>Baylor College of Medicine, Houston, TX, USA</td></tr>
		</table>
	]]></Data_Provider>
	<StudyNameEntrez>The Human Gut Microbiome and Recurrent Abdominal Pain in Children</StudyNameEntrez>
	<StudyNameReportPage>The Human Gut Microbiome and Recurrent Abdominal Pain in Children</StudyNameReportPage>
	<StudyTypes>
		<StudyType>Case-Control</StudyType>
	</StudyTypes>
	<Description><![CDATA[
<p>This project explores the nature of the human intestinal microbiome in healthy children and children with recurrent 	abdominal pain. The overall goal is to obtain a robust knowledge-base of the intestinal microbiome in children without 	evidence of pain or gastrointestinal disease, children with functional abdominal pain, and children with abdominal pain 	and changes in bowel habits (irritable bowel syndrome).  Multiple strategies have been deployed to navigate and understand 	the nature of the intestinal microbiome in childhood. These strategies include 454 pyrosequencing-based strategies to 	sequence 16S rRNA genes and understand the detailed composition of microbes in healthy and disease groups. Microarray-based 	hybridization with the PhyloChip and quantitative real-time PCR (qPCR) probes are being applied as complementary strategies 	to gain an understanding of the intestinal microbiome from various perspectives. Data collected and analyzed during the 	HMP UH2 and UH3 Demo project, from a set of healthy and IBS children may enable the identification of core microbiomes in children 	in addition to variable components that may distinguish healthy from diseased pediatric states.  We are currently analyzing 	the dataset for the presence of disease-specific signatures in the human microbiome, and correlating these microbial 	signatures with pediatric health or IBS disease status.  This study explores the nature of core and variable human 	microbiomes in pre-adolescent healthy children and children with recurrent abdominal pain.</p>]]>
	</Description>
	<StudyInEx><![CDATA[
<p><b>Inclusion Criteria:</b></p> 	<p>Children aged 7-12 years of age who either have IBS or FAP or are healthy without complaints (Controls).</p> 	<p>IBS: 		<ol> 			<li>Minimum of 1 healthcare visit for abdominal pain.</li> 			<li>Minimum number of pain episodes of at least once per month, for three consecutive months within the year prior 			to enrolling in study.</li> 			<li>Pain episodes have been severe enough to cause functional impairment; or have prompted medication use; or have been 			rated moderate to severe (&#8805; 3/10).</li> 			<li>Symptoms current.</li> 			<li>Less than 95th percentile blood pressure for age.</li> 		</ol> 	</p> 	<p>Controls: 		<ol> 			<li>Asymptomatic with regards to abdominal pain and without significant chronic health issues.</li> 			<li>Less than 95% blood pressure for age</li> 		</ol> 	</p> 	<p><b>Exclusion Criteria:</b></p> 	<p>IBS/FAP: 		<ol> 			<li>Organic disease that accounts for abdominal pain.</li> 			<li>Child currently taking an anti-inflammatory medication, or if their abdominal pain responded to an 			anti-inflammatory medication in the past.</li> 			<li>Child currently taking medication for reflux to which abdominal pain symptoms are responding.</li> 			<li>Other chronic health condition or chronic illness (except mild intermittent or mild persistent asthma).</li> 			<li>Cognitive impairment significantly below average age and/or grade level.</li> 			<li>Vomiting &#8805; 2 times per month within 3 months prior to enrolling on study.</li> 			<li>Unintentional weight loss of &#8805; 5% body weight within 3-month period.</li> 			<li>Females who have menses.</li> 			<li>Use of the following drugs within the last 6 months: systemic antibiotics, oral, intravenous, intramuscular, 			nasal or inhaled corticosteroids, cytokines, methotrexate or immunosuppressive cytotoxic agents, or large doses 			of commercial probiotics (10e8 cfu per day or higher).</li> 			<li>Major diet change in the past month prior to enrollment (e.g., change to vegetarianism or vice versa; avoidance 			or inclusion of major food group [fruit, vegetables]). This does not include diet changes related to lactose intolerance.</li> 			<li>Major surgery including surgery involving the gastrointestinal tract.</li> 		</ol> 	</p> 	<p>Controls: 		<ol> 			<li>Other chronic illness or health condition or chronic illness (except mild intermittent or mild persistent asthma)</li> 			<li>Cognitive impairment significantly below average age and/or grade level</li> 			<li>Child seen a physician more than once in past year for abdominal pain unexplained by common illness (e.g., gastroenteritis)</li> 			<li>Females who have menses</li> 			<li>Use of the following drugs within the last 6 months: systemic antibiotics, oral, intravenous, intramuscular, nasal or 			inhaled corticosteroids, cytokines, methotrexate or immunosuppressive cytotoxic agents, or large doses of commercial 			probiotics (10e8 cfu per day or higher).</li> 			<li>Major diet change in the past month prior to enrollment (e.g., change to vegetarianism or vice versa; avoidance 			or inclusion of major food group [fruit, vegetables]). This does not include diet changes related to lactose intolerance.</li> 			<li>Major surgery including surgery involving the gastrointestinal tract.</li> 			<li>Non-English speaking parent or child.</li> 		</ol> 	</p>]]>
	</StudyInEx>
	<StudyProjects>
		<Project/>
	</StudyProjects>
	<Publications>
		<Publication>
			<Pubmed pmid="21741921"/>
		</Publication>
		<Publication>
			<Journal authors="Kevin Riehle, Cristian Coarfa, Andrew Jackson, Jun Ma, Arpit Tandon, Sameer Paithankar, Sriram Raghuraman, Toni-Ann Mistretta, Delphine Saulnier, Sabeen Raza, Maria Alejandra Diaz, Robert Shulman, Kjersti Aagaard, James Versalovic,  Aleksandar Milosavljevic" title="The Genboree Microbiome Toolset and the Analysis of 16S rRNA Microbial Sequences" journal="BMC Bioinformatics 2011. Submitted"/>
		</Publication>
	</Publications>
	<Diseases>
		<Disease vocab_source="MESH" vocab_term="Irritable Bowel Syndrome"/>
		<Disease vocab_source="MESH" vocab_term="Digestive System Diseases"/>
		<Disease vocab_source="MESH" vocab_term="Abdominal Pain"/>
	</Diseases>
	<Attributions>
		<Header title="Principal Investigator">
			<AttName>James Versalovic, MD, PhD</AttName>
			<Institution>Baylor College of Medicine, Texas Children&#39;s Hospital, Houston, TX,  USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>1UH3DK083990-02</AttName>
			<Institution>National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Co-Investigator Clinical">
			<AttName>Robert J. Shulman, MD</AttName>
			<Institution>Baylor College of Medicine, Texas Children&#39;s Hospital, Houston, TX,  USA</Institution>
		</Header>
		<Header title="Clinical Research Coordinator III">
			<AttName>Erica Weidler Baimbridge</AttName>
			<Institution>Baylor College of Medicine, Houston, TX, USA</Institution>
		</Header>
		<Header title="Clinical Research Coordinator II">
			<AttName>Michelle Rubio-Gonzales</AttName>
			<Institution>Baylor College of Medicine, Houston, TX, USA</Institution>
		</Header>
		<Header title="Instructor responsible for sample preparation and logistics, data analysis">
			<AttName>Jennifer Spinler, PhD</AttName>
			<Institution>Baylor College of Medicine, Houston, TX, USA</Institution>
		</Header>
		<Header title="Instructor responsible for sample preparation and logistics, data analysis">
			<AttName>Ruth Ann Luna, PhD</AttName>
			<Institution>Baylor College of Medicine, Houston, TX, USA</Institution>
		</Header>
		<Header title="Responsible for data analysis, data management and logistics. Biostatistician, Bioinformatician">
			<AttName>Toni-Ann Mistretta, PhD</AttName>
			<Institution>Baylor College of Medicine, Houston, TX, USA</Institution>
		</Header>
		<Header title="Instructor responsible for data analysis, WGS, metatranscriptomics analysis development. Bioinformatician">
			<AttName>Emily B. Hollister, PhD</AttName>
			<Institution>Baylor College of Medicine, Houston, TX, USA</Institution>
		</Header>
		<Header title="Bioinformatician, Data Analyst, Pipeline Development">
			<AttName>Kevin Riehle, MS</AttName>
			<Institution>Baylor College of Medicine, Houston, TX, USA</Institution>
		</Header>
		<Header title="Database design and management, Data Analyst">
			<AttName>Sabeen Raza, MS</AttName>
			<Institution>Baylor College of Medicine, Houston, TX, USA</Institution>
		</Header>
		<Header title="Postdoctoral Associate Sample Preparation, qPCR, Data Analysis">
			<AttName>Maria Alejandra Diaz, PhD</AttName>
			<Institution>Baylor College of Medicine, Houston, TX, USA</Institution>
		</Header>
		<Header title="Bioinformatician">
			<AttName>Cristian Coarfa, PhD</AttName>
			<Institution>Baylor College of Medicine, Houston, TX, USA</Institution>
		</Header>
		<Header title="Other Collaborator Pipeline Development">
			<AttName>Aleksandar Milosavljevic, PhD</AttName>
			<Institution>Baylor College of Medicine, Houston, TX, USA</Institution>
		</Header>
		<Header title="Other Collaborator (Clinical)">
			<AttName>Bruno P. Chumpitazi, MD</AttName>
			<Institution>Baylor College of Medicine, Houston, TX, USA</Institution>
		</Header>
		<Header title="Other Collaborator (Sequencing)">
			<AttName>Joe Petrosino, PhD</AttName>
			<Institution>Baylor College of Medicine, Houston, TX, USA</Institution>
		</Header>
		<Header title="Other Collaborator (Sequencing)">
			<AttName>Sarah Highlander, PhD</AttName>
			<Institution>Baylor College of Medicine, Houston, TX, USA</Institution>
		</Header>
		<Header title="Other Collaborator (Sequencing)">
			<AttName>Richard Gibbs, PhD</AttName>
			<Institution>Baylor College of Medicine, Houston, TX, USA</Institution>
		</Header>
		<Header title="Other Collaborator (Sequencing)">
			<AttName>Bonnie P. Youmans</AttName>
			<Institution>Baylor College of Medicine, Houston, TX, USA</Institution>
		</Header>
		<Header title="Other Collaborator (Sequencing)">
			<AttName>Matthew Clayton Ross</AttName>
			<Institution>Baylor College of Medicine, Houston, TX, USA</Institution>
		</Header>
		<Header title="Other Collaborator (Sequencing)">
			<AttName>Xiang Qin, PhD</AttName>
			<Institution>Baylor College of Medicine, Houston, TX, USA</Institution>
		</Header>
		<Header title="Other Collaborator (Sample Preparation for Sequencing)">
			<AttName>Tulin Ayvaz</AttName>
			<Institution>Baylor College of Medicine, Houston, TX, USA</Institution>
		</Header>
	</Attributions>
	<DisplayPublicSummary>yes</DisplayPublicSummary>
	<StudyHistory><![CDATA[
<p>This study is part of the NIH Road Map Human Microbiome Project. The first subject was enrolled on August 2009. The first phase of     the study enrolled 26 Pediatric IBS (PIBS) and 22 Pediatric Control (PCtrl) subjects. 4 PIBS dropped out of the study.  Multiple     samples were collected from some of the subjects at 2-3 month intervals.  22 PCtrl were samples collected as follows: 17 were     sampled once (1x), 1 was sampled twice (2x), and 5 were sampled three times (3x). PIBS subjects were collected as     follows: 13 - 1x, 3 - 2x, 6 - 3x.  Data analysis has been completed for these 71 samples representing 22 PCtrl and 22 PIBS.     These 71 samples have been sequenced (454) and analyzed by phylochip (55) and qPCR.  The UH3 portion of the study has currently     enrolled a total of 1 Pediatric IBS (PIBS), 28 Pediatric Control (PCtrl) and 3 Pediatric FAP (PFAP) subjects. 1 PCtrl and 1 PFAP     have been excluded by the time of the study description submittal. Three (3) samples per subject are being collected at 2 month     intervals.  19 PCtrl (7 - 1x; 2 - 2x; 10 - 3x), 1 PIBS (1 - 2x) and 2 PFAP (1 - 2x; 1 - 3x) (5 samples) subjects have submitted samples     for a total of 49 samples.  These samples have been extracted for 16S rRNA gene sequencing (454).  Of these, 46 samples have been     sequenced and are currently in the pipeline for data analysis. Additional samples are currently being collected and processed     and will be submitted for 16S rRNA gene sequencing. Deep 16S rRNA, WGS, and meta-RNA analysis will be performed on samples     chosen from the UH3 samples. Sequence data from the UH2 and UH3 samples will be combined and submitted for in-depth analysis.</p>]]>
	</StudyHistory>
	<ConsentGroups>
		<ConsentGroup groupNum="1" shortName="HMP" longName="Human Microbiome Research"/>
	</ConsentGroups>
</Configuration>

  <AuthorizedAccess>
    <DacInfo ssDacId="0">
      <DacName>NIDDK</DacName>
      <DacFullName>NIDDK Central Repository GWAS Data Access Committee</DacFullName>
      <DacEmail>niddk-dac@mail.nih.gov</DacEmail>
      <DacPhone></DacPhone>
      <DacFax>301-480-3510</DacFax>
      <DacUrl>http://www3.niddk.nih.gov/researchprograms/repositories/FAQ.shtml</DacUrl>
    </DacInfo>
    <Policy Policy_ID="phs000265.v3.p1_policy" ref_ssDacId="0">
      <DisplayResearchStatement>yes</DisplayResearchStatement>
      <DisplayPublicSummary>yes</DisplayPublicSummary>
      <EmbargoLength>12</EmbargoLength>
      <YearsUntilRenewal>1</YearsUntilRenewal>
      <WeeksCancelRequest>8</WeeksCancelRequest>
      <PdfSupplementReqired>no</PdfSupplementReqired>
      <AcknowledgementText>
        <para>
               http://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000265.v3.p1
            </para>
      </AcknowledgementText>
      <DocumentSet>
        <DataUseCertificate Label="Data Use Certificate" FilePath="https://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000265.v3.p1" FileName="HMP_PedAbdominalInflammation_versalovich.pdf"/>
      </DocumentSet>
    </Policy>
    <ConsentGroups>
      <ParticipantSet groupNum-REF="1">
        <ConsentName>Human Microbiome Research</ConsentName>
        <ConsentAbbrev>HMP</ConsentAbbrev>
        <UseLimitation>Studies related to the human microbiome.
Sequence data generated from microbiome samples will be used only for the purpose of studying the microbial components of the microbiome and will not be used to make inferences about the human host DNA itself.</UseLimitation>
        <IrbRequired>No</IrbRequired>
      </ParticipantSet>
    </ConsentGroups>
  </AuthorizedAccess>
  <Documents>
    <Document phd="phd002765.1" type="consent-form" createDate="2010-05-25" modDate="2011-09-13" urlToXml="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/GetDocumentXml.cgi?document_id=phd002765.1" urlToHtml="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/document.cgi?study_id=phs000265.v3.p1&amp;phd=2765">
      <OrigName>HMP_AbPain_CONSENT FORM.doc</OrigName>
      <DisplayName>CONSENT FORM</DisplayName>
      <Description>CONSENT FORM</Description>
      <displayStatus>public</displayStatus>
      <xmlStatus>public</xmlStatus>
    </Document>
    <Document phd="phd002766.1" type="protocol" createDate="2010-05-25" modDate="2011-09-13" urlToXml="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/GetDocumentXml.cgi?document_id=phd002766.1" urlToHtml="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/document.cgi?study_id=phs000265.v3.p1&amp;phd=2766">
      <OrigName>HMP_AbPain_MODIFIED_IRBCOLLECTION_STUDYINFO.doc</OrigName>
      <DisplayName>Institutional Review Board Protocol</DisplayName>
      <Description>Institutional Review Board Protocol</Description>
      <displayStatus>public</displayStatus>
      <xmlStatus>public</xmlStatus>
    </Document>
    <Document phd="phd002767.2" type="questionnaire" createDate="2011-09-12" modDate="2011-09-13" urlToXml="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/GetDocumentXml.cgi?document_id=phd002767.2" urlToHtml="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/document.cgi?study_id=phs000265.v3.p1&amp;phd=2767">
      <OrigName>HMP_AbPain_RAP Daily Diary with numbers Compilation 01-13-09.doc</OrigName>
      <DisplayName>RAP Daily Diary</DisplayName>
      <Description>RAP Daily Diary</Description>
      <displayStatus>public</displayStatus>
      <xmlStatus>public</xmlStatus>
    </Document>
    <Document phd="phd002768.2" type="protocol" createDate="2011-09-12" modDate="2011-09-13" urlToXml="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/GetDocumentXml.cgi?document_id=phd002768.2" urlToHtml="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/document.cgi?study_id=phs000265.v3.p1&amp;phd=2768">
      <OrigName>HMP_AbPain_RAP Tx Daily Diary Instruction.doc</OrigName>
      <DisplayName>RAP Treatment Daily Diary: Instructions</DisplayName>
      <Description>RAP Treatment Daily Diary: Instructions</Description>
      <displayStatus>public</displayStatus>
      <xmlStatus>public</xmlStatus>
    </Document>
    <Document phd="phd003700.1" type="protocol" createDate="2011-10-07" modDate="2011-10-07" urlToXml="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/GetDocumentXml.cgi?document_id=phd003700.1" urlToHtml="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/document.cgi?study_id=phs000265.v3.p1&amp;phd=3700">
      <OrigName>PIBS_HMP_Demo_Proj_Prog_Rpt_Y2H2.docx</OrigName>
      <DisplayName>NIH HMP Demonstration Project Twice-Yearly Progress Report</DisplayName>
      <Description>NIH HMP Demonstration Project Twice-Yearly Progress Report</Description>
      <displayStatus>public</displayStatus>
      <xmlStatus>public</xmlStatus>
    </Document>
  </Documents>

  <Annotations>
    <DocumentPart phd="phd002766.1" sectionId="p1">
      <phvList>
        <phvRef variableId="91107"/>
        <phvRef variableId="91111"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd002767.2" sectionId="sec0a">
      <phvList>
        <phvRef variableId="91115"/>
        <phvRef variableId="91116"/>
        <phvRef variableId="91117"/>
        <phvRef variableId="91118"/>
        <phvRef variableId="91119"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd002767.2" sectionId="sec0b">
      <phvList>
        <phvRef variableId="91122"/>
        <phvRef variableId="91123"/>
        <phvRef variableId="91124"/>
        <phvRef variableId="91125"/>
        <phvRef variableId="162759"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd002768.2" sectionId="sec1">
      <phvList>
        <phvRef variableId="91115"/>
        <phvRef variableId="91116"/>
        <phvRef variableId="91117"/>
        <phvRef variableId="91118"/>
        <phvRef variableId="91119"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd002768.2" sectionId="sec2">
      <phvList>
        <phvRef variableId="91122"/>
        <phvRef variableId="91123"/>
        <phvRef variableId="91124"/>
        <phvRef variableId="91125"/>
        <phvRef variableId="162759"/>
      </phvList>
    </DocumentPart>
  </Annotations>



</Study>

</Studies>

</GaPExchange>
